TABLE 4.
Individual and group regression coefficients and variance explained in knee laxity by changes in estradiol, progesterone, and testosterone across the menstrual cycle.
| Regression Coefficients with Constant (*P < 0.01)
|
|||||||||
|---|---|---|---|---|---|---|---|---|---|
| Subject | R2 | Const | E | P | T | E*P | E*T | P*T | E*P*T |
| 6 | 63.53% | 2.38 | 1.42E−02* | 4.47E−01* | 2.25E−02* | −4.03E−03* | −2.78E−04* | −9.09E−03* | 8.41E−05* |
| 8 | 62.76% | 5.56 | −9.83E−02* | −2.22E+00 | −8.94E−03 | 9.08E−02* | 1.42E−03* | 2.11E−02 | −1.41E−03* |
| 9 | 66.28% | −2.95 | 6.27E−02* | 1.76E+00* | 1.26E−01* | −1.26E−02* | −1.04E−03* | −3.08E−02* | 2.17E−04* |
| 14 | 68.89% | 3.00 | 1.39E−02* | −7.81E−01* | −1.06E−02 | 4.80E−03 | −6.13E−04* | 1.76E−02* | −9.86E−05 |
| 15 | 66.89% | 11.91 | −6.32E−02* | −1.74E+00* | −1.14E−01* | 1.59E−02* | 1.24E−03* | 2.49E−02* | −2.43E−04* |
| 16 | 66.51% | 5.94 | −8.48E−02* | −5.04E+00* | −1.09E−01* | 1.07E−01* | 3.12E−03* | 1.67E−01* | −3.43E−03* |
| 17 | 72.35% | −0.30 | 4.92E−02* | 3.38E+00* | 1.78E−01* | −2.46E−02* | −1.46E−03* | −1.40E−01* | 8.70E−04* |
| 19 | 78.09% | 5.11 | −6.08E−03 | 1.59E+00* | −2.92E−02 | −1.76E−02* | 3.56E−04 | −2.81E−02* | 3.54E−04* |
| 20 | 60.44% | 10.89 | −3.62E−02* | −4.01E−01* | −1.22E−01* | 4.83E−03* | 1.05E−03* | 7.79E−03* | −1.08E−04* |
| 21 | 50.51% | 0.64 | 4.22E−02* | 2.70E−01 | 3.57E−02 | −5.05E−03* | −7.89E−04* | 3.00E−03 | 6.79E−05 |
| 23 | 59.70% | 2.30 | 1.87E−02* | 1.27E+00* | 8.58E−02* | −5.97E−03* | −3.39E−04* | −2.34E−02* | 1.11E−04* |
| 25 | 69.76% | 3.24 | 3.66E−02* | 2.88E+00* | 5.48E−02* | −3.42E−02* | −7.91E−04* | −5.95E−02* | 7.14E−04* |
| 26 | 59.03% | 3.95 | 8.86E−03* | −1.97E−01* | −3.32E−02* | 2.97E−04 | −8.80E−06 | 5.82E−03* | −1.14E−05 |
| 27 | 48.64% | −0.22 | 5.58E−02* | 8.57E−01* | 1.20E−01* | −8.32E−03* | −1.26E−03* | −2.33E−02* | 2.07E−04* |
| 29 | 57.28% | −0.80 | 4.71E−02* | 2.01E−01 | 1.77E−01* | 3.10E−03 | −9.49E−04* | −1.78E−03 | −1.25E−04 |
| 30 | 69.41% | 2.42 | 1.36E−02* | −1.46E+00* | 6.45E−02* | 8.97E−03* | −4.19E−04* | 4.68E−02 | −3.08E−04 |
| 33 | 72.68% | 2.36 | 2.42E−02* | 2.06E+00* | 1.13E−01* | −1.67E−02* | −1.06E−03* | −7.11E−02* | 6.14E−04* |
| 34 | 65.83% | 24.08 | −2.05E−01* | −5.72E+00* | −6.44E−01* | 5.50E−02* | 6.40E−03* | 1.88E−01* | −1.84E−03* |
| 35 | 58.77% | 14.67 | −1.00E−01* | −3.59E+00* | −1.39E−01* | 4.64E−02* | 1.79E−03* | 5.57E−02 | −7.07E−04* |
| 36 | 55.17% | 15.54 | −1.17E−01* | −2.62E+00* | −3.47E−01* | 3.07E−02* | 4.03E−03* | 1.18E−01* | −1.41E−03* |
| 37 | 51.12% | 13.32 | −2.34E−02* | 7.51E−01* | −9.06E−02* | −1.41E−02* | 3.70E−04 | −1.62E−02* | 3.13E−04* |
| 38 | 68.93% | 5.41 | 2.01E−02* | 4.87E−01* | 7.87E−02* | −3.89E−03* | −7.00E−04* | −3.22E−02* | 2.23E−04* |
| Mean | 63.30% | 2.94 | 9.10E−03 | 2.21E−01 | 4.42E−02 | 5.75E−03 | −2.11E−04 | −7.79E−03 | −1.27E−04 |
| Group | 7.60% | 0.01 | 4.19E−03* | −1.28E−02* | 9.35E−03* | −5.80E−05 | 8.84E−05* | −2.39E−04 | −3.44E−05* |
E, estradiol; P, progesterone; T, testosterone.
Significant contribution to the model, P < 0.01.